Dow Down 0.62% Nasdaq Up 0.35%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
1.30 0.00(0.00%) Feb 9
Prev Close:1.30
Open:1.31
Bid:1.25
Ask:2.98
1y Target Est:N/A
Beta:2.50425
Earnings Date:May 10 - May 16 (Est.)
Day's Range:1.26 - 1.38
52wk Range:1.18 - 11.50
Volume:88
Avg Vol (3m):5,262
Market Cap:50.54M
P/E (ttm):N/A
EPS (ttm):-1.07
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

» More Headlines for TTH.TO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback